Immunoglobulin A is an antibody that plays a role in the immune function of mucous membranes. The amount of IgA produced in association with mucosal membranes is greater than all other types of antibody combined. From Wikipedia
Phase 1/2 results position APRIL pathway blockade as a key driver of pathogenic IgA1 reduction with a global Phase 3 trial underway.
